6550--FY25: CEPHEID Molecular Platforms Reagents B+4
SAM.GOV Due: January 30, 2025 at 06:00 PM UTC
In-Active Special Notice Source Url

Summary

The opportunity titled "6550--FY25: CEPHEID Molecular Platforms Reagents B+4" is a special notice indicating the government's intent to award a sole source contract to Cepheid for the provision of specific reagents required by the Orlando Healthcare System. This procurement is being conducted under the authority of 41 USC 3304(a)(1) and FAR 6.302-1, which allows for sole source contracts when only one source is deemed capable of fulfilling the requirement. Contractors with the technical capability to meet these specific needs are encouraged to submit a complete technical package by the response deadline. This opportunity is particularly suited for businesses that specialize in medical reagents and have the necessary certifications and capabilities to meet the stringent requirements of the Department of Veterans Affairs.
Description
Special Notice Special Notice Page 3 of 3 Special Notice *= Required Field Special Notice Page 1 of 3 NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT TO Cepheid, 904, EAST CARIBBEAN DRIVE, SUNNYVALE, CA 94089, for Cepheid Reagents for the Orlando Healthcare System, 13800 Veterans Way, Orlando, F
Entities
VADO
Department of Veterans Affairs
NAICS
325413
Set Aside
None
Place of Performance
Point of Contact
Full Name Email Phone Type
Benjamin M Amato [email protected] 407-646-4005 primary
Attachments
  • SN+36C24825Q0311.pdf